End of Content.
Get the latest creative news from us about politics, business, sport and travel
End of Content.
Innovation where it matters: human well-being, machines, and the planet. This section focuses on applied science and engineering breakthroughs, medical revolutions, AI frontiers, and emerging tech that reshapes how we live and heal.
Could digital health tools like AI and wearables finally deliver equality in chronic care or repeat old inequalities?
Why do some athletes stop improving months after ACL surgery despite ongoing physiotherapy and successful reconstruction?
If the tau protein is essential for Alzheimer's disease, why do therapies fail? Human stem cell neurons reveal one tau form that changes everything.
Humans still lead service systems, are intelligent technologies truly replacing frontline workers, or strengthening their judgement? New research maps six transformation pathways.
Immune cells enter the tumour early: What happens when immune cells are injected directly into breast tumours before chemotherapy, and can this change how cancer is treated?
Does automation really eliminate jobs? Learn how AI redistributes tasks and creates new roles across entire work systems.
Can artificial intelligence truly understand every society or is it amplifying inequality worldwide through hidden cultural assumptions?
Can changing the light color make vegetables healthier and more nutritious? Discover how LED technology is transforming modern agriculture.
Could a rigid sense of self quietly fuel depression, and could a more flexible way of relating to ourselves support well-being?
Could wood-based membranes replace expensive synthetic filters in the global fight against polluted drinking water?
Can technology truly solve global challenges without understanding people? Discover why humility and context matter more than innovation alone.
Why adopting AI is no longer optional for Malaysian SMEs, and how it is driving efficiency and innovation across...
A new bioinformatics tool transforms proteogenomics by exposing false positives. Will this reshape how medicine targets Alzheimer’s and cancer?
